About Triquetra Medicines

At Triquetra Medicines, we are obsessively patient-focused. Patients and physicians have the right to expect innovative, high-quality pharmaceutical products with maximized therapeutic effects, optimized safety, high availability, and affordable prices. Sacrificing any of these qualities creates an imbalance for patients and Public Health.

​With aging populations and ever more stressed Public Health budgets, the demand for more, better, and affordable medicines is paramount. However, current R&D models are unlikely to meet such demands. We show that there are other ways to develop much-needed medicines for patients and Public Health.

​We innovate in the space between traditional brand product and generic companies. We focus on identifying and developing drug product opportunities from academic research and pharma R&D with high therapeutic validation in areas of high unmet medical need, complemented with innovative product-specific sales and support models. Our products don't fit the high expectations of brand product companies; generics companies lack the necessary R&D capabilities. Our model provides an additional source of prescription medicines to expensive brand products and old generics. In short, for the pharmacy industry a third leg to stand on.

​We can develop faster, cheaper, at lower risks, and sell at much lower prices. Our products represent the same modern efficacy, safety, and quality standards as new brand products but sell at prices close to generics.